Delaware
(State
or other jurisdiction
of
incorporation)
|
1-9813
(Commission
File
Number)
|
94-2347624
(I.R.S.
Employer
Identification
No.)
|
[ ]
|
Written
communications pursuant to Rule 425 under the Securities Act (17
CFR
230.425)
|
[ ]
|
Soliciting
material pursuant to Rule 14a-12 under the Exchange Act (17 CFR
240.14a-12)
|
[ ]
|
Pre-commencement
communications pursuant to Rule 14d-2(b) under the Exchange Act
(17 CFR
240.14d-2(b))
|
[ ]
|
Pre-commencement
communications pursuant to Rule 13e-4(c) under the Exchange Act
(17 CFR
240.13e-4(c))
|
ITEM 2.02.
|
RESULTS
OF OPERATIONS AND FINANCIAL
CONDITION
|
ITEM 8.01.
|
OTHER
EVENTS
|
ITEM 9.01.
|
FINANCIAL
STATEMENTS AND EXHIBITS
|
(d)
|
Exhibits.
|
Exhibit
No.
|
||
99.1
|
Earnings
Press Release of Genentech, Inc. dated January 14,
2008.
|
|
99.2
|
Consolidated
Statements of Income and Selected Consolidated Financial
Data
|
GENENTECH,
INC.
|
|||
Date:
|
January
14, 2008
|
/s/ARTHUR
D. LEVINSON
|
|
Arthur
D. Levinson, Ph.D.
Chairman
and Chief Executive Officer
|
|||
Date:
|
January
14, 2008
|
/s/DAVID
A. EBERSMAN
|
|
David
A. Ebersman
Executive
Vice President and
Chief
Financial Officer
|
|||
Date:
|
January
14, 2008
|
/s/ ROBERT
E. ANDREATTA
|
|
Robert
E. Andreatta
Controller
and Chief Accounting Officer
|
Exhibit
No.
|
Description
|
99.1
|
Earnings
Press Release of Genentech, Inc. dated January 14,
2008.
|
99.2
|
Consolidated
Statements of Income and Selected Consolidated Financial
Data
|